EPI-DOSE
Dead / Abandoned — Abandoned — after inter partes decision (as of 10 Dec 2014)
What this means for you
This application is over — abandoned 10 Dec 2014. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86151049
- Mark type
- Stylized text
- Filed
- 23 Dec 2013
- Published for opposition
- 27 May 2014
- Abandoned
- 10 Dec 2014
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes; Vitamin and mineral preparations for medical use
Owner
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
- Asepsis Pharmaceuticals Inc., North Stonington, CT, US
Prior registrations
Prosecution history
- 10 Dec 2014 — ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
- 10 Dec 2014 — ABANDONMENT - AFTER INTER PARTES DECISION
- 10 Dec 2014 — OPPOSITION TERMINATED NO. 999999
- 10 Dec 2014 — OPPOSITION SUSTAINED NO. 999999
- 16 Sept 2014 — OPPOSITION INSTITUTED NO. 999999
- 10 Jun 2014 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 May 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2014 — PUBLISHED FOR OPPOSITION
- 07 May 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Apr 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 21 Apr 2014 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Apr 2014 — EXAMINER'S AMENDMENT ENTERED
- 21 Apr 2014 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 21 Apr 2014 — EXAMINERS AMENDMENT E-MAILED
- 21 Apr 2014 — EXAMINERS AMENDMENT -WRITTEN